PART 1: QTL MAPPING: BEHAVIORS AND TOXINS
=========================================

BEHAVIOR AS A QTL ENDPOINT FOR TOXICOLOGY STUDIES
-------------------------------------------------

There are two main reasons why behavioral assays are so useful in detecting effects of toxins. First is their richness. Behavior can be described as an ongoing, generally complex, spatio-temporal pattern; subtle changes in that pattern can signal the action of very low doses of a toxin well before there are dramatic changes in organ systems: in children overt clinical encephalopathy is associated with blood lead levels of 80--100 μ/dl, while changes in intelligence quotient (IQ) and learning occur at or below a tenth of that dose ([@B51]). Second is that even subtle toxin-dependent changes in behavior can have consequences for well-being which makes them meaningful and relevant.

Since chronic developmental exposure to toxins affects assembly of the neuronal and hormonal systems mediating adult behavior, their effects are generally more pronounced than that following acute adult exposure. Developmental exposure to sub-lethal and sub-teratogenic levels of toxins may alter or degrade physiological and behavioral mechanisms in a quantitative manner. Examples include effects of low doses of lead on behavior in fruit flies ([@B16]), cognitive effects of polychlorobiphenyls in people ([@B14]), lead effects on cognitive function in people ([@B9]), and the effects of aluminum on adult behavior and developmental rate of their offspring in mice ([@B1]). Once toxin-dependent behavioral changes are observed, the next steps may include study of their underlying physiological effects, for example, effects of lead on synaptic function in fruit fly larvae ([@B15]).

The bulk of what is known about the effects of various toxins is based on studies focusing on a single toxin; combinations of toxins can have additive, protective, or synergistic effects ([@B39]; [@B47]).

*DROSOPHILA* BEHAVIORAL QTLs
----------------------------

Quantitative trait locus (QTL) mapping is used for unbiased genome-wide screens to identify genetic loci causing variation in a trait, but they are most efficient when large numbers of individual genomes can be assayed. The large sample sizes required for precise QTL analysis favors model organisms that can be bred in the lab easily and inexpensively, and traits that are simple to assay yet rich in their information content and thus provide sensitive measures of effects of toxins are especially desirable.

*Drosophila* is an ideal model organism for both efficiency and genetic analysis, since they are easy and relatively inexpensive to breed and maintain in large numbers, and have a surprising degree of genetic homology to mammals ([@B30]). Because of the small physical size of *Drosophila* many phenotypic traits can be difficult to assay rapidly or quantitatively. Exceptions include very simple traits such as bristle number, or those easy to quantify such as number of offspring; others may be easy to automate given an investment in the required technical support.

Automated phenotypic assays in *Drosophila*tend to favor either gene expression during embryogenesis, where molecular marker extraction and detection can be automated, or locomotor behavior which, by using *Drosophila* Activity Monitors (DAMs), can be recorded relatively easily for large numbers of flies over periods of many days **Figure [1](#F1){ref-type="fig"}**; TriKinetics Inc., Waltham, MA, USA; [@B41]; [@B42]).

![**(A)** *Drosophila* Activity Monitor with glass tubes containing one adult fly, food at the far end and a cotton plug visible on the other end of each tube. **(B)** A behavioral QTL at region 30AB of *Drosophila melanogaster* chromosome two, for changes in activity level induced by developmental exposure to lead.](fgene-03-00068-g001){#F1}

The richness of the data gathered using DAMs makes it an ideal automated assay for genetic analysis of toxins. DAM data always provides, at a minimum, an estimate of mean locomotor activity level for the duration of the experiment. However, by measuring locomotor activity under the influence of a controlled light--dark cycle the photosensitivity pattern of activity can be analyzed. Using regulated light--dark cycles allows for determining the distribution of activity between the two phases of the photoperiod; the effect of light--dark cycle length other than 24 h; the amplitude of "daily" activity rhythms, the percentage of flies that show significant daily rhythms; and the timing, length, and distribution of sleep periods ([@B46]).

Finally, by replacing light--dark cycles with constant darkness the free-running circadian period can be estimated. This provides a direct measure of the output of the biological circadian pacemaker driving the activity rhythm. Toxins that alter the circadian periodicity pattern of locomotor activity are likely, therefore, to perturb the circadian synchronization of many different biological functions regulated by a common central circadian clock. Temporal analysis of behavioral effects of toxins could also suggest the presence of daily rhythms in sensitivity to specific toxins, or in the manifestation of toxic effects. In humans, certain forms of cancer chemotherapy are more effective when administered at specific times of day ([@B23]; [@B25]); other toxins may also vary in their effects during the rhythm of daytime sunlight and nighttime darkness.

In short, DAMs allow for analysis of toxic effects on both the level of locomotor activity *per se* and on its temporal pattern of expression ([@B52]; [@B33]).

*DROSOPHILA* ACTIVITY MONITORS AND ACTIVITY ASSAYS
--------------------------------------------------

Behavioral toxicogenetic analysis is a relatively new application of DAM technology. DAMs were originally devised for genetic analysis of the circadian oscillator controlling locomotor activity. Locomotor activity in fruit flies, similar to running wheel activity in rodents, is an excellent reporter phenotype for underlying circadian clock function ([@B50]). Since precise analysis of circadian rhythms require frequent, continuous long-term data sampling for time-series estimation of periodic oscillations in the 24-h range, DAMs are designed to produce a data-rich profile of the locomotor activity of individual fruit flies. Flies are housed, usually singly, in a 5 mm × 60 mm transparent tube with enough food to last for approximately 2 weeks. A single monitor holds 32 tubes, and a photobeam in the center of each tube tracks locomotor activity as numbers of beam-crossing per unit of time, usually 10-min intervals.

*Drosophila* Activity Monitors permit a variety of experimental designs. It is relatively easy to assay developmental effects of toxins by adding them to the fly culture food during egg, larval, or pupal development, and then monitoring adults. Effects of toxins can also be assayed acutely by adding them to the food in the activity monitor tubes. A single DAM, approximately 5^″^ long, 4^″^ high, and 3^″^ deep holds 32 flies so one refrigerator-sized incubator can house thousands of flies per experiment. The efficiency of DAMs facilitates experimental analysis of sex differences, dose--response curves, sensitive periods during development, interaction among multiple toxins, *trans*-generational effects, and various types of genetic analysis including behavioral QTL. It is also just as easy to monitor survival time of individual flies to the minute in assays of lethal toxic effects and degrees of resistance to them.

BEHAVIORAL QTL ANALYSIS OF DEVELOPMENTAL EXPOSURE TO TOXINS
-----------------------------------------------------------

We have identified a toxin-induced behavioral QTL by assaying locomotor activity levels for a set of recombinant inbred (RI) fly lines raised on medium containing 250 μM lead acetate or control medium made with 250 μM sodium acetate. The variation among the RI fly lines in the difference in mean activity level per line between the two treatments indicated a behavioral QTL in the 30AB region of the second *Drosophila* chromosome **Figure [1](#F1){ref-type="fig"}**; [@B17]). This QTL was independently identified as the site of an expression QTL (eQTL) in response to the same lead treatment in the same set of RI lines (RILs). Using the gene expression assay, we further showed the 30AB eQTL to function as a master modulatory regulator of approximately 70 additional eQTLs throughout the genome in response to developmental lead exposure ([@B43]). Current research underway in our labs will map these behavioral QTLs in response to developmental lead exposure more precisely.

PART 2: SYNAPSES AND Ca^2+^ REGULATION IN *DROSOPHILA*
======================================================

Early findings suggested that chronic Pb^2+^ exposure could produce its behavioral effects by altering synaptic development. Mammalian studies reported a variety of alterations in synaptic morphology and physiology in the brains of animals exposed to Pb^2+^ during development ([@B36]; [@B22]; [@B2]). Today, the synapse remains a focus for studying the effects of toxins on brain development. Here the *Drosophila* larval neuromuscular junction (NMJ) offers a distinct advantage since one can compare the same, identified synapse in controls and treated animals (**Figure [2](#F2){ref-type="fig"}**). Note that this neuromuscular system is unique even amongst invertebrates because there is a stereotypic pattern of neuromuscular connections where both the presynaptic (motor neuron) and postsynaptic cells (muscle fiber) can be uniquely identified ([@B21]). These neuromuscular synapses have been used to demonstrate the effects of second messengers, cell-adhesion molecules and their modulators, and impulse activity on synaptic development ([@B6]; [@B7]; [@B10]).

![**Ca^2+^ transients recorded from identified synaptic terminals in control and Pb^2+^-exposed animals**. (Left) The RP3 motor terminals on MF6 were filled with OGB-1 in control larvae and in those exposed to Pb^2+^. The arrows point to two typical synaptic boutons where Ca^2+^ transients were measured. (Right) Typical Ca^2+^ transients produced by single action potentials (AP) and AP trains for control and Pb^2+^-exposed boutons. For single APs, the Ca^2+^ transients were similar for control and Pb^2+^-exposed synaptic boutons; however, the Ca^2+^ transients produced by AP trains were larger and decayed more slowly in Pb^2+^-exposed boutons compared to controls. Calibration: single Ap -- 20% ΔF/F, 0.4 s; AP train -- 20% ΔF/F, 2 s. Adapted from [@B15].](fgene-03-00068-g002){#F2}

We found that indeed one could detect synaptic abnormalities resulting from chronic Pb^2+^ exposure at the *Drosophila* larval NMJ. Initial studies found that the motor terminal formed by motoneuron RP3 on Muscle Fiber 6 (MF6) showed greater variability in size for animals raised in media containing Pb^2+^ compared to controls ([@B34]). One could imagine that increasing the variability of synaptic size could result in a loss of fine-tuning of synaptic function; this effect, if seen in the brain, would likely be detrimental to circuit dynamics and behavior. It is noteworthy that this synaptic change was subtle and it likely would have been difficult to detect when making comparisons among a large population of synapses in the mammalian brain. Given that the behavioral effects of toxins, such as Pb^2+^, can be subtle, it seems reasonable that the effects on synapses might also be small.

Pb^2+^ affects proteins that bind Ca^2+^ including those that regulate the intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~), such as Ca^2+^ channels and Ca^2+^ pumps. Changes in Ca^2+^ regulation could be particularly important for the synapse since \[Ca^2+^\]~i~ controls multiple steps in synaptic development; e.g., growth cone guidance ([@B20]), synapse formation ([@B54]), and synapse elimination and stabilization ([@B38]; [@B28]). In addition, altered Ca^2+^ regulation could influence transmitter release ([@B56]) and both long-term and short-term forms of synaptic plasticity at the mature synapse ([@B57]; [@B29]).

Acute Pb^2+^ exposure blocks Ca^2+^ channels. This has been demonstrated for a variety of voltage-dependent Ca^2+^ channels in both invertebrates ([@B3]) and mammals ([@B13]). The acute application of micromolar concentrations of Pb^2+^ can reduce the activity of the plasma membrane Ca^2+^ ATPase (PMCA) in humans and rats ([@B32]; [@B44], [@B45]); however the PMCA can be stimulated by low Pb^2+^ concentrations ([@B32]; [@B8]). In addition, chronic*in vivo* Pb^2+^ exposure has been found to produce a persistent inhibition of PMCA activity in human erythrocytes ([@B8]) and rat synaptosomes ([@B44], [@B45]).

We studied the effect of chronic Pb^2+^ exposure on presynaptic Ca^2+^ regulation at the RP3-to-MF6 synapse in *Drosophila* larvae ([@B15]). Ca^2+^ indicators were loaded in these motor terminals and we measured the changes in \[Ca^2+^\]~i~ produced by single action potentials and action potential trains (**Figure [2](#F2){ref-type="fig"}**). We found that chronic exposure to Pb^2+^ resulted in a greater increase in \[Ca^2+^\]~i~ during trains of action potentials and a slower decay of postsynaptic \[Ca^2+^\]~i~ at the end of the train. This is likely due to a decrease in the activity of the PMCA and it provides an interesting parallel to the effect of Pb^2+^ exposure on the PMCA in mammals. The direct effect of this large increase in \[Ca\]~i~ was that the Pb^2+^-exposed animals showed greater synaptic facilitation. This was consistent with the residual Ca^2+^ model for synaptic facilitation ([@B57]) and with mammalian studies showing that knocking down expression of the PMCA resulted in enhanced synaptic facilitation ([@B12]). In that study, reduced PMCA expression also produced changes in neuronal structure ([@B12]) and it may be that the Pb^2+^-induced changes in the structure of the larval NMJ resulted from reduced PMCA activity and altered Ca^2+^ regulation.

In summary, identified NMJs in *Drosophila* larvae allow for the detection of subtle changes in synaptic structure and function resulting from developmental exposure to toxins. Our evidence suggests that chronic Pb^2+^ exposure produces parallel synaptic changes in *Drosophila* and mammals; this would not be surprising given that chemical synapses found in vertebrates and invertebrates are very similar.

PART 3: GENETICAL GENOMICS STUDIES IN *DROSOPHILA*
==================================================

Developmental neurotoxicology research requires an approach that reduces the candidate toxin-regulated genes to a manageable number. Fortunately, a new multi-dimensional strategy has been developed, called genetical genomics, which identifies master modulatory loci that regulate the expression of hundreds of other genes ([@B19]; [@B4]; [@B11]; [@B24]; [@B40]). Genetical genomics combines two methodologies, microarray-based whole transcriptome analyses and extracting QTLs by using RILs. Global gene expression levels are determined for each RIL, and then QTL mapping software (e.g., R/QTL; [@B5]) is used to find above-threshold statistical associations between specific chromosomal loci and transcript levels for all the genes measured on the microarrays. With QTL analysis, we can identify the specific chromosomal loci that regulate genes, which are referred to as eQTLs ([@B35]; [@B53]; [@B31]; [@B55]).

Our research is the first that combines genetical genomics with toxicogenomics, an experimental approach we call "genetical toxicogenomics" ([@B43]). [@B27] showed that adding environmental perturbations in genetical genomics studies, as we did in our study ([@B43]), allows toxin-response genes to be identified. We believe that this genetical toxicogenomics approach will drive the field of toxicology and aid in understanding the effects of toxins such as lead.

Expression QTL analyses were performed for all \~18,000 genes and other microarray features by treating the expression level of each gene as a quantitative trait. The genetics of gene expression in RILs can be mapped as eQTLs. Flies from each of 75 RILs were fed, from egg to adult, either control food or lead-treated food (made with 250 μM lead acetate). RNA expression analyses of whole adult male flies (5--10 days old) were performed with Affymetrix Dros2 whole genome arrays (18,952 probe sets). Loci that are linked to a gene are called locally acting or *cis*-eQTL, whereas loci that are distantly acting are called *trans*-eQTLs ([@B4]).

The first genetical genomics study to identify genes with significant GxE interactions was done in *Caenorhabditis elegans*; the authors identified a group of genes with *trans*-eQTL that are induced by heat shock, which they called plastic QTL ([@B26]). [@B48] recently performed a detailed analysis of GxE-eQTL in yeast (which they call "*gxe*QTL") grown in either glucose or ethanol as the sole carbon source. Others have identified GxE interactions in which the environment is a different tissue (e.g., brain *vs.* liver; [@B18]). In our studies, among the 1,389 genes with *cis*-eQTL, there were 405 genes unique to control flies and 544 genes unique to lead-treated ones (440 genes had the same *cis*-eQTLs in both samples).

There were 2,396 genes with *trans*-eQTL that mapped to 12 major hotspots that met statistical significance (*p* \< 0.05, chi-squared test, based on permutation analyses, on 5-cM windows). Unexpectedly, we identified two hotspots, one located on the second chromosome (polytene region 30AB) and one on the third chromosome (polytene region 73D), which co-regulate 33 genes, all of which are induced by lead (**Figure [3](#F3){ref-type="fig"}**). We have shown by QTL analysis that marker locus 30AB contributes to lead-dependent changes in locomotion, which suggests that the genes in the 30AB hotspot can be used as a functional test to identify both the lead-dependent *trans*-regulatory factor and the common *cis*-regulatory motifs ([@B17]). We propose that a *trans*-regulator located at 73D increases expression of its target genes when it binds lead, regardless of the genotype of the 73D hotspot. In contrast, a second *trans*-regulator located at 30AB increases expression of the co-regulated target genes only when it has the *ORE* genotype (**Figure [3](#F3){ref-type="fig"}**).

![**Genetical genomics results of *Drosophila* recombinant inbred lines with developmental lead exposure. (A)** The *x*-axis is the chromosome locations of the *cis*- and *trans*-eQTLs in centimorgans (cM). The *y*-axis is the location of the transcript in mega-base pairs (Mbp). The eQTLs in control (red) and the eQTLs treated (black) are indicated as dots and crosses, respectively. The locations of the control *trans*-eQTL are shown on top in red and the lead-treated *trans*-eQTL locations are shown in black letters. Many of the eQTL at 70D in the control flies shift to 30AB in the lead-treated flies (red arrow at top). **(B)** The *trans*-activator encoded by the 73D hotspot is required for basal transcription of the 33 genes co-regulated by both 73D and 30AB master modulatory genes. **(C)** In the presence of lead, the *trans*-regulator encoded by the 73D hotspot further increases steady-state mRNA levels when it has either the ORE or 2B genotype. However, the *trans*-regulator encoded by the 30AB hotspot further increases steady-state mRNA levels for the 33 target genes only when it has the ORE genotype. Adapted from [@B43].](fgene-03-00068-g003){#F3}

This model can explain the data, but other explanations are possible. For example, the putative *trans*-regulator could increase the stability of the mRNA of the target genes, or there could be an indirect effect on steady-state mRNA levels. MEME (Multiple Em for Motif Elicitation) analyses of the genes regulated by the 30AB and 73D *trans*-regulators identified both conserved proximal promoter and 3′-untranslated region (UTR) sequences (data not shown). Fine-mapping of the genes that underlie the QTLs and molecular and biochemical analyses should enable us to determine the mechanism involved.

FUTURE STUDIES IN *DROSOPHILA* NEUROTOXICOLOGY
==============================================

In this review, we describe recent results from several laboratories that are collaborating on studying the effects of lead on the developing *Drosophila* nervous system. The Possidente and Hirsch laboratories study the effects of lead on behavioral quantitative traits. The Lnenicka laboratory studies the effects of lead on the NMJ in the larvae. The Ruden, Lu, and Garfinkel laboratories study the effects of lead on gene expression using quantitative genetics techniques.

Further innovations to the field of genetical genomics will make use of next-generation RNA sequencing (RNA-seq) rather than gene expression microarrays. RNA-seq will allow us not only to accurately determine gene expression levels, but also to analyze alternative splicing products of genes, thereby adding a new dimension to these studies. Since over 90% of human genes and a similar percentage of *Drosophila* genes are alternatively spliced, RNA-seq could provide some exciting and novel findings about environmental regulation of alternative mRNA splicing. The potential for RNA-seq to supplant microarrays requires, however, the development of robust statistical tools for analyzing the resulting huge datasets.

Adding metabolomics profiling to these studies will allow us to identify metabolite QTL (mQTL) that are specific for lead. To our knowledge mQTL analyses have never been conducted in any organism, although genome-wide association studies combined with metabolic profiling were conducted in a recent human study ([@B37]; [@B49]). The human study identified 37 genetic loci associated with blood metabolite concentrations, of which 25 showed effect sizes of 10--60% which is extraordinarily high for genome-wide association studies ([@B37]; [@B49]).

We are now entering the stage of understanding the complex genetic pathways that are affected by developmental lead exposure. The sophisticated genetic analyses that are possible in *Drosophila* will soon allow us to manipulate these pathways to better understand how they are affected by lead. The sequencing of several *Drosophila* strains and studying the effects of lead on neurodevelopment in these strains will allow us to better understand the evolution of lead-sensitive pathways. Together, these studies will provide a better understanding of the health effects of lead in humans.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This work was supported by NIH R01 grants ES012933 to Douglas M. Ruden, and DK071073 to Xiangyi Lu.

[^1]: Edited by: *Michael Aschner, Vanderbilt University Medical Center, USA*

[^2]: Reviewed by: *Eugenia Xu, Raymond and Beverly Sackler Foundation, USA Marcos De Donato, Cornell University, USA*

[^3]: This article was submitted to Frontiers in Toxicogenomics, a specialty of Frontiers in Genetics.
